Interest in interests in photodynamic therapy: Reply from authors [20]

British Journal of Dermatology

Volumn 156, Issue 6, 2007, Pages 1393-

  Caekelbergh, K ^a   Annemans, L ^a,b  

^a IMS HEOR   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; HEALTH ECONOMICS; HUMAN; LETTER; MEDICAL DECISION MAKING; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PUBLIC HEALTH; UNITED KINGDOM; UNITED STATES;

EID: 34447104754     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07911.x     Document Type: Letter

References (3)

1. Caekelbergh K, Annemans L, Lambert J, Roelandts R. Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma. Br J Dermatol 2006 155 : 784 90.
2. Rhodes LE, de Rie M, Enstrom Y et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004 140 : 17 23.
3. Basset-Séguin N, Ibbotson S, Emtestam L et al. Photodynamic therapy using methyl aminolevulinate is as efficacious as cryotherapy in superficial BCC, with better cosmetic results: results of a European randomized and multicenter study. J Dermatolog Treat 2004 15 : 266 (Abstr.).